Literature DB >> 19250162

Botulinum toxin cosmetic therapy correlates with a more positive mood.

Michael B Lewis1, Patrick J Bowler.   

Abstract

BACKGROUND: It has been suggested that botulinum toxin A (BTX-A) treatment for frown lines can also be used as a treatment for depression. A psychological mechanism for this effect is reviewed in which paralysis of the corrugator (frown) muscles leads to less facial feedback for negative emotions. Consequently, a negative affect is harder to maintain and so the person has a more positive mood.
METHODS: In order to test this mechanism, the mood of patients who had received BTX-A treatment for glabelar frown lines was measured and compared with patients who had received other cosmetic treatments.
RESULTS: The BTX-A-treated patients showed significantly less negative mood.
CONCLUSION: The results support the facial feedback view that frowning can make one unhappier. Treatments that prevent frowning correlate with reduced negative mood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250162     DOI: 10.1111/j.1473-2165.2009.00419.x

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  24 in total

1.  Behavior Analysts to the Front! A 15-Step Tutorial on Public Speaking.

Authors:  Patrick C Friman
Journal:  Behav Anal       Date:  2014-05-20

2.  [Lidocaine-containing hyaluronic acid filler on a CPM® basis for lip augmentation : Experience from clinical practice].

Authors:  T Fischer; G Sattler; G Gauglitz
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

3.  [The satisfied patient in aesthetic dermatology. Consensus work on patient satisfaction in botulinum toxin A treatment].

Authors:  O P Kreyden; B Rzany; P Becker-Wegerich; C Boudny-Frey; P Carrozza-Merlani; M Hess-Schmid; B Schlagenhauff
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

Review 4.  Treatment of Depression with Botulinum Toxin.

Authors:  Marc Axel Wollmer; Michelle Magid; Tillmann H C Kruger; Eric Finzi
Journal:  Toxins (Basel)       Date:  2022-05-31       Impact factor: 5.075

Review 5.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

6.  Impact of botulinum toxin a on the quality of life of subjects following treatment of facial lines.

Authors:  Ravi Jandhyala
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

Review 7.  Understanding Emotions: Origins and Roles of the Amygdala.

Authors:  Goran Šimić; Mladenka Tkalčić; Vana Vukić; Damir Mulc; Ena Španić; Marina Šagud; Francisco E Olucha-Bordonau; Mario Vukšić; Patrick R Hof
Journal:  Biomolecules       Date:  2021-05-31

Review 8.  Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

9.  The functional role of the periphery in emotional language comprehension.

Authors:  David A Havas; James Matheson
Journal:  Front Psychol       Date:  2013-05-27

10.  Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations.

Authors:  Paul S Yamauchi
Journal:  Patient Prefer Adherence       Date:  2010-09-07       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.